Microbot Medical (MBOT) Assets Average (2011 - 2026)

Microbot Medical's Assets Average history runs 16 years deep, the most recent figure standing at $79.8 million for Q1 2026.

• Quarterly Assets Average rose 332.28% year-over-year to $79.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.8 million (up 332.28% YoY) and the FY2025 annual result came in at $43.8 million, up 509.94% from the prior year.
• Assets Average was $79.8 million for Q1 2026 at Microbot Medical, down from $81.7 million in the prior quarter.
• Across five years, Assets Average topped out at $81.7 million in Q4 2025 and bottomed at $5.6 million in Q4 2024.
• A 5-year average of $22.1 million and a median of $9.0 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average plunged 56.81% — and 2025, when it soared 1353.01%.
• Microbot Medical's Assets Average stood at $8.5 million in 2022, then grew by 1.59% to $8.6 million in 2023, then tumbled by 34.71% to $5.6 million in 2024, then surged by 1353.01% to $81.7 million in 2025, then slipped by 2.26% to $79.8 million in 2026.
• Business Quant data shows MBOT's Assets Average at $79.8 million in Q1 2026, $81.7 million in Q4 2025, and $57.4 million in Q3 2025.